As of [date], Johnson & Johnson (JNJ) stock closed at $178.92 per share, marking a 0.56% increase from the previous trading session. The stock has been trading within a range of $173.00 to $182.25 over the past 52 weeks, with a current market capitalization of approximately $479 billion.
In its most recent quarterly report, Johnson & Johnson reported revenue of $23.7 billion, a 2.6% increase year-over-year. The company's net income reached $6.2 billion, representing a 5.1% increase from the same period last year. JNJ's strong financial performance has been driven by its diverse healthcare portfolio, which includes pharmaceuticals, medical devices, and consumer health products.
Analysts are generally bullish on JNJ stock, with a consensus rating of "Buy." According to FactSet, the average 12-month price target for JNJ is $192.00, implying potential upside of over 7%. Analysts cite the company's strong market position, innovative pipeline, and resilient earnings as key reasons for their bullish stance.
Johnson & Johnson is well-positioned for long-term growth due to:
Based on industry trends, analyst estimates, and the company's long-term growth prospects, it is projected that JNJ stock could reach between $230 and $260 by 2025. This implies a compound annual growth rate (CAGR) of approximately 4-6%.
Johnson & Johnson Stock Price Forecast 2025: Growth Potential Amid Healthcare Demand
Table 1: Historical Johnson & Johnson Stock Performance
Year | Revenue (USD billions) | Net Income (USD billions) |
---|---|---|
2021 | 93.8 | 14.7 |
2022 | 96.5 | 16.4 |
2023 (Q1) | 23.7 | 6.2 |
Table 2: Analyst Price Targets for JNJ Stock
Analyst | 12-Month Price Target |
---|---|
Goldman Sachs | $195.00 |
Morgan Stanley | $189.00 |
Credit Suisse | $193.00 |
Table 3: JNJ Stock Price Forecast 2025
Scenario | Price Range |
---|---|
Bullish | $230-$260 |
Bearish | $180-$200 |
Table 4: Johnson & Johnson Key Financials
Metric | Value |
---|---|
Market Cap | $479.0 billion |
P/E Ratio (TTM) | 24.56 |
Dividend Yield | 2.42% |
Investing in JNJ stock provides exposure to a well-established and diversified healthcare company with strong growth potential. The company's long history of innovation and brand recognition make it a reliable choice for investors seeking long-term returns.
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-12-24 20:51:08 UTC
2024-12-30 18:28:52 UTC
2025-01-04 00:57:59 UTC
2024-12-21 05:42:35 UTC
2024-09-21 04:01:29 UTC
2024-09-21 04:01:48 UTC
2024-12-07 22:30:53 UTC
2024-12-08 13:14:55 UTC
2025-01-08 06:15:39 UTC
2025-01-08 06:15:39 UTC
2025-01-08 06:15:36 UTC
2025-01-08 06:15:34 UTC
2025-01-08 06:15:33 UTC
2025-01-08 06:15:31 UTC
2025-01-08 06:15:31 UTC